Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration

Multiple sclerosis (MS) progresses through brain region-specific inflammation and degeneration, with poorly defined mechanisms. In individuals with MS, we identified increased expression of formyl peptide receptor 1 (FPR1) in central nervous system (CNS)-resident microglia and CNS-infiltrating macrophages. Blood amounts of <i>N</i>-formylated peptides, which are endogenous agonists of FPR1, correlated with disease progression in patients with MS. In MS mouse models, signaling through FPR1 promoted microglial mitochondrial dysfunction, causing axonal loss and apoptosis. FPR1-expressing microglia sustained the clonal expansion of myelin-reactive CD4<sup>+</sup> T cells in the CNS. A CNS-penetrating small molecule FPR1 antagonist, T0080, mitigated autoimmune responses and axonal degeneration. Our study identifies FPR1 signaling as a potential mechanism for MS progression and suggests antagonizing FPR1 as a therapeutic approach.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-11-13
DOI
https://doi.org/10.1126/science.adq1177
Citations
6
Primary Topic
S100 Proteins and Annexins
Type
article
Field-Weighted Citation Impact
4.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration

Zhihui Qi, Chotima Böttcher, Shuzhen Guan, Lei Su et al.
6 citations
Science
S100 Proteins and Annexins
4.84
article

Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration

Zhihui Qi, Chotima Böttcher, Shuzhen Guan, Lei Su, Friedemann Paul, Nan Yao, Siting Wu, Alexei Verkhratsky, Luc Van Kaer, X. Zhang, Hans‐Gustaf Ljunggren, Meng Wang, Zhiguo Li, Xue Zhao, Yan Li, Jing Jing, Fu‐Dong Shi, Pei Zheng, Yulin Li
article en
6 citations

Abstract

Multiple sclerosis (MS) progresses through brain region-specific inflammation and degeneration, with poorly defined mechanisms. In individuals with MS, we identified increased expression of formyl peptide receptor 1 (FPR1) in central nervous system (CNS)-resident microglia and CNS-infiltrating macrophages. Blood amounts of <i>N</i>-formylated peptides, which are endogenous agonists of FPR1, correlated with disease progression in patients with MS. In MS mouse models, signaling through FPR1 promoted microglial mitochondrial dysfunction, causing axonal loss and apoptosis. FPR1-expressing microglia sustained the clonal expansion of myelin-reactive CD4<sup>+</sup> T cells in the CNS. A CNS-penetrating small molecule FPR1 antagonist, T0080, mitigated autoimmune responses and axonal degeneration. Our study identifies FPR1 signaling as a potential mechanism for MS progression and suggests antagonizing FPR1 as a therapeutic approach.

ScienceVol. 390(6774)
Karolinska University Hospital (SE), Vanderbilt University (US), Max Delbrück Center (DE), Tianjin Medical University General Hospital (CN), Karolinska Institutet (SE), University of Manchester (GB), Beijing Tian Tan Hospital (CN)
Openalex Percentile: Top 5%
S100 Proteins and Annexins
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.